TIDMODX
RNS Number : 7933A
Omega Diagnostics Group PLC
24 January 2020
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Grant of Options under Company EMI Plan
Omega Diagnostics (AIM: ODX), the medical diagnostics company
focused on CD4, food intolerance and allergy testing, announces
that certain Directors and PDMRs were granted options on 23 January
2020 (the "Grant Date") to subscribe for an aggregate of 3,150,000
ordinary shares of 4 pence each in the capital of the Company
("Ordinary Shares") at an exercise price of 15.4 pence per Ordinary
Share (the "Options"). The Options are being granted under the
Company's 2020 EMI Plan. The Options shall have a two-year vesting
period, after which the Option may then be exercised in whole or in
part in accordance with the Rules of the Plan.
A full break down of Directors and PDMRs being granted the
Options is provided below:
Name Director or Current Proposed Total Options
PDMR Options Option award after award
Chief Executive
Colin King Officer 1,200,000 950,000 2,150,000
------------------ ----------- -------------- --------------
Group Finance
Kieron Harbinson Director 940,000 750,000 1,690,000
------------------ ----------- -------------- --------------
Group Commercial
Jag Grewal Director 910,000 500,000 1,410,000
------------------ ----------- -------------- --------------
Edward Valente PDMR 300,000 100,000 400,000
------------------ ----------- -------------- --------------
Mike Gordon PDMR 290,000 100,000 390,000
------------------ ----------- -------------- --------------
Jamie Yexley PDMR 225,000 100,000 325,000
------------------ ----------- -------------- --------------
Patrick Breen PDMR 45,000 150,000 195,000
------------------ ----------- -------------- --------------
Angela Robertson PDMR 25,000 100,000 125,000
------------------ ----------- -------------- --------------
John Bannister PDMR 230,000 100,000 330,000
------------------ ----------- -------------- --------------
Derek Brady PDMR 0 150,000 150,000
------------------ ----------- -------------- --------------
Jill Hepburn PDMR 0 150,000 150,000
------------------ ----------- -------------- --------------
Total 4,165,000 3,150,000 7,315,000
----------- -------------- --------------
The Options issued to Colin King, Kieron Harbinson and Jag
Grewal contain an additional performance condition which states the
Option shall not be capable of being exercised unless and until the
middle-market quotation of a Share is equal or greater than 30p at
any time on or after the second anniversary of the Grant Date,
after which the Option may then be exercised in whole or in part in
accordance with the Rules of the Plan as if no further Performance
Condition applied.
Following the Option award, there are a total of 13,645,406
unexercised options over Ordinary Shares in the Company,
representing 9.07 per cent. of the issued share capital.
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. The below notification
is made in accordance with the requirements of the EU Market Abuse
Regulation.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030
Bill Rhodes, Interim Non-Executive www.omegadiagnostics.com
Chairman
Colin King, Chief Executive
Kieron Harbinson, Group Finance
Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Hannah Boros (Corporate
Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Kieron Harbinson
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status Group Finance Director
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 750,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Colin King
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status CEO
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 950,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Jag Grewal
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status Group Commercial Director
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 500,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Edward Valente
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 100,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Mike Gordon
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 100,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Jamie Yexley
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 100,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Patrick Breen
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 150,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Angela Robertson
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 100,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name John Bannister
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 100,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Derek Brady
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 150,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
--------------------------------------------------------------- -----------------------------------------------
a) Name Jill Hepburn
2 Reason for the notification
---- --------------------------------------------------------------- -----------------------------------------------
a) Position / status PDMR
---- --------------------------------------------------------------- -----------------------------------------------
Initial notification / amendment Initial notification
---- --------------------------------------------------------------- -----------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Omega Diagnostics Group PLC
---- --------------------------------------------------------------- -----------------------------------------------
b) LEI 2138007U9P4BTZTYIR92
---- --------------------------------------------------------------- -----------------------------------------------
4 Details of the transaction(s): section to be prepared for (i) each type of instrument; (ii)
each type of transaction; (iii) each date and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 4p each ("Ordinary Shares")
--------------------------------------------------------------- -----------------------------------------------
Identification code ISIN: GB00B1VCP282
---- --------------------------------------------------------------- -----------------------------------------------
b) Nature of transaction Grant of Options
---- --------------------------------------------------------------- -----------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
n/a 150,000
----------
---- --------------------------------------------------------------- -----------------------------------------------
d) Aggregated information As above
---- --------------------------------------------------------------- -----------------------------------------------
e) Date of the transaction 23 January 2020
---- --------------------------------------------------------------- -----------------------------------------------
f) Place of the transaction N/a
---- --------------------------------------------------------------- -----------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEAEFDADFEEAA
(END) Dow Jones Newswires
January 24, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Apr 2023 a Apr 2024
